Exact Sciences

Receiving a metastatic breast cancer diagnosis can be overwhelming. Genomic tests like the OncoExTra® test can help uncover additional treatment and clinical trial options. Today, let’s build a community of support for those living with metastatic breast cancer. Learn some myths and misconceptions about metastatic breast cancer via Breastcancer.org: https://bit.ly/4f1b89B #MetastaticBreastCancerDay

We must work together to improve breast cancer outcomes in Black women, and it starts with representation in clinical trials. Know the facts and learn more via When We Trial: https://bit.ly/3zPlv1p Touch, The Black Breast Cancer Alliance #BreastCancerAwarenessMonth

You’ve likely heard of the breast cancer genes, BRCA1 and BRCA2. All women have two copies of these genes, but certain inherited variations can lead to a higher lifetime risk for breast cancer. Learn more and access resources via FORCE: Facing Our Risk of Cancer Empowered, an organization dedicated to empowering the hereditary cancer community: https://bit.ly/4gSgfLf #BreastCancerAwarenessMonth

We’re proud to be named to Fortune's Best Workplaces in BioPharma list! This recognition wouldn’t be possible without our incredible employees; their passion and commitment are what makes Exact Sciences a great place to work. https://bit.ly/3N7Yk5E #WeAreExact

We are hiring for summer interns! At Exact Sciences, interns tackle real-world projects that help change lives, through hands-on work related to their career interests or studies. Join us virtually at tomorrow’s “Internship Insider” to learn more about Exact Sciences and our internship program: https://lnkd.in/gZDhivCw

Our Customer Care team members make sure our patients, providers, and health care partners get the support they need. In recognition of their outstanding efforts, we celebrate #CustomerServiceWeek. Thank you for all you do! #WeAreExact

Major milestone alert! Cologuard Plus™, our next-generation Cologuard® test, is now FDA approved. With 95% sensitivity for colorectal cancer and 43% sensitivity for advanced precancers, it sets a new performance standard for noninvasive screening, providing early detection that enables disease prevention. Read the full press release: https://bit.ly/4evGC7Z

We all play a role in building a supportive breast cancer community for patients and survivors. Whether you’d like to start small or dive in headfirst, here are five ways you can make a difference: https://bit.ly/3TPKNn6 Katie Couric Media #BreastCancerAwarenessMonth

Every person’s breast cancer experience is different, but there’s one thing that could help anyone facing a diagnosis: answers. Over the past 20 years, the Oncotype DX® test has empowered breast cancer patients to make more informed, personalized treatment decisions. #20YearsofOncotypeDX #BreastCancerAwarenessMonth

Every 14 seconds a woman is diagnosed with breast cancer somewhere in the world. Everyone has a role to play in the fight against this disease. This October, join us in raising awareness and advocating for the most diagnosed cancer in women worldwide. #BreastCancerAwarenessMonth